Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07563829 |
| Title | NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | NextPoint Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California - San Diego | La Jolla | California | 92093 | United States | Details | |
| Johns Hopkins | Baltimore | Maryland | 21287 | United States | Details | |
| Montefiore | The Bronx | New York | 10461 | United States | Details | |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| NEXT | Fairfax | Virginia | 22031 | United States | Details |